Epiminder (ASX:EPI) 3-Month Share Buyback Ratio: 0.00% (As of Dec. 2025 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:EPI Epiminder Ltd ASX:EPI
8 GF Score
Price A$0.46
View Full Analysis

What is Epiminder 3-Month Share Buyback Ratio?

Epiminder ASX:EPI +4.55% 8 3-Month Share Buyback Ratio is 0.00 as of Dec. 2025. GuruFocus rates ASX:EPI with a GF Score™ of 8/100.

3-Month Share Buyback Ratio only apply to companies whose reporting frequency is 3 months.

ASX:EPI
8GF Score
Epiminder Ltd ASX:EPI
3-Month Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a 3-Month Share Buyback Ratio of 0.00 mean?
Epiminder (ASX:EPI) has a 3-Month Share Buyback Ratio of 0.00 as of Dec. 2025. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Epiminder and its competitors.
Is Epiminder's 3-Month Share Buyback Ratio too high?
Epiminder's current 3-Month Share Buyback Ratio is 0.00. Overall, Epiminder has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Epiminder's 3-Month Share Buyback Ratio compare to ABT and SYK?
Epiminder's 3-Month Share Buyback Ratio of 0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Month Share Buyback Ratio for a Medical Devices & Instruments company?
A good 3-Month Share Buyback Ratio depends on the Medical Devices & Instruments industry context. However, 3-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Month Share Buyback Ratio mean?
A high 3-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Epiminder and its competitors. Epiminder's current 3-Month Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Epiminder stock overvalued right now?
Epiminder (ASX:EPI) has a current 3-Month Share Buyback Ratio of 0.00. The current 3-Month Share Buyback Ratio is 0.00. Epiminder's overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Month Share Buyback Ratio calculated?
3-Month Share Buyback Ratio is calculated from a company's financial statements. For Epiminder (ASX:EPI), the current 3-Month Share Buyback Ratio is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Epiminder Business Description

Address 525 Collins Street, 210 West Podium, Mezzanine 2, Melbourne, VIC, AUS, 3000
Epiminder Ltd is a medical device and information solutions company focused on developing diagnostic and treatment tools for epilepsy. Its system is a sub-scalp device for continuous monitoring of electrographic brain activity and a set of information solutions, providing patients and their healthcare professionals with detailed data over an extended period.
8GF Score

Get the complete analysis for ASX:EPI

3-Month Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.46
Price